Summary In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
All Keywords
【저자키워드】 coronavirus, Immunosuppression, Glomerulonephritis, Hyperinflammatory syndrome, Kidney disease, 【초록키워드】 coronavirus disease, IgG, Glucocorticoids, coronavirus, risk, risk factor, glucocorticoid, Case report, Seroconversion, Mild, disease, Intensive, Mild disease, SARS-CoV‑2, Glucocorticoid treatment, nephrotic syndrome, severe coronavirus disease, syndrome, SARS-CoV‑2 infection, the patient, baseline, 【제목키워드】 IgG, Seroconversion, Patient, disease, Intensive, Glucocorticoid treatment,
【저자키워드】 coronavirus, Immunosuppression, Glomerulonephritis, Hyperinflammatory syndrome, Kidney disease, 【초록키워드】 coronavirus disease, IgG, Glucocorticoids, coronavirus, risk, risk factor, glucocorticoid, Case report, Seroconversion, Mild, disease, Intensive, Mild disease, SARS-CoV‑2, Glucocorticoid treatment, nephrotic syndrome, severe coronavirus disease, syndrome, SARS-CoV‑2 infection, the patient, baseline, 【제목키워드】 IgG, Seroconversion, Patient, disease, Intensive, Glucocorticoid treatment,
요약 이 사례 보고서에서는 SARS-CoV-2 감염과 동시에 초기 신증후군으로 인한 집중 글루코코르티코이드 치료를 받은 중증 코로나바이러스 질환(COVID 19)에 대한 다중 위험 인자를 가진 환자의 드문 사례를 제시합니다. 이 높은 기준선 위험 프로필과 글루코코르티코이드 사용에도 불구하고 환자는 IgG SARS-CoV-2 혈청 전환을 포함한 가벼운 질병만 발병했습니다.